다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

AADI

Aadi Bioscience (AADI)

Aadi Bioscience Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:AADI

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/24	06:30	PR Newswire (US)	Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:AADI	Aadi Bioscience Inc
2024/05/09	05:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AADI	Aadi Bioscience Inc
2024/05/08	21:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AADI	Aadi Bioscience Inc
2024/05/08	21:00	PR Newswire (US)	Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate Update	NASDAQ:AADI	Aadi Bioscience Inc
2024/05/01	21:01	PR Newswire (US)	Aadi Bioscience to Report First Quarter 2024 Results and Corporate Update	NASDAQ:AADI	Aadi Bioscience Inc
2024/04/09	21:00	PR Newswire (US)	Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research (AACR) Annual Meeting	NASDAQ:AADI	Aadi Bioscience Inc
2024/03/17	21:00	PR Newswire (US)	Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)	NASDAQ:AADI	Aadi Bioscience Inc
2024/03/13	21:00	PR Newswire (US)	Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Update	NASDAQ:AADI	Aadi Bioscience Inc
2024/03/06	22:00	PR Newswire (US)	Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update	NASDAQ:AADI	Aadi Bioscience Inc
2024/03/06	06:30	PR Newswire (US)	Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024	NASDAQ:AADI	Aadi Bioscience Inc
2024/03/05	09:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/03/05	09:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/03/05	09:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/03/02	06:08	PR Newswire (US)	Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa	NASDAQ:AADI	Aadi Bioscience Inc
2024/03/02	03:07	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/02/27	06:05	PR Newswire (US)	Aadi Bioscience to Present at the TD Cowen 44th Annual Healthcare Conference	NASDAQ:AADI	Aadi Bioscience Inc
2024/02/13	07:21	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:AADI	Aadi Bioscience Inc
2024/02/13	07:16	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:AADI	Aadi Bioscience Inc
2024/02/03	07:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/01/27	06:05	PR Newswire (US)	Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium	NASDAQ:AADI	Aadi Bioscience Inc
2024/01/20	06:05	PR Newswire (US)	Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium	NASDAQ:AADI	Aadi Bioscience Inc
2024/01/03	09:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2023/12/15	07:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AADI	Aadi Bioscience Inc
2023/12/15	06:05	PR Newswire (US)	Aadi Bioscience Reports Interim Results from PRECISION1 Trial of nab-Sirolimus Demonstrating Anti-Tumor Activity in Solid Tumors with TSC1 or TSC2 Inactivating Alterations	NASDAQ:AADI	Aadi Bioscience Inc
2023/12/08	06:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2023/12/06	08:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2023/12/02	01:37	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AADI	Aadi Bioscience Inc
2023/11/09	06:54	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AADI	Aadi Bioscience Inc
2023/11/09	06:28	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:AADI	Aadi Bioscience Inc
2023/11/08	22:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AADI	Aadi Bioscience Inc

검색 관련기사 보기:NASDAQ:AADI

1 2 3 4 5 6 다음 >>

US Dollar vs Yen

American Express

Health Care Select Sector

Energy Select Sector SPDR

Bank of America

Gold vs US Dollar

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관